GLP1R and metabolic dysfunction-associated steatotic liver disease: Zhou et al. found that serum GLP-1 concentrations were significantly elevated after NaB treatment, although improved insulin sensitivity did not reach statistical significance in HFD-fed NAFLD mice (36).